| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
73,004 |
33,257 |
$4.61M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
72,438 |
32,943 |
$1.53M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,105 |
5,908 |
$104K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
82 |
61 |
$4K |
| 80053 |
Comprehensive metabolic panel |
219 |
144 |
$212.85 |
| 80061 |
Lipid panel |
204 |
139 |
$71.23 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
258 |
164 |
$43.48 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
227 |
147 |
$28.10 |
| 36415 |
Collection of venous blood by venipuncture |
484 |
307 |
$21.16 |
| 99000 |
|
8,211 |
6,942 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
92 |
58 |
$0.00 |